Association between High On-Aspirin Platelet Reactivity and Reduced Superoxide Dismutase Activity in Patients Affected by Type 2 Diabetes Mellitus or Primary Hypercholesterolemia.

International Journal of Molecular Sciences
Cristina BaraleIsabella Russo

Abstract

Platelet hyperactivation is involved in the established prothrombotic condition of metabolic diseases such as Type 2 Diabetes Mellitus (T2DM) and familial hypercholesterolemia (HC), justifying the therapy with aspirin, a suppressor of thromboxane synthesis through the irreversible inhibition of cyclooxygenase-1 (COX-1), to prevent cardiovascular diseases. However, some patients on aspirin show a higher than expected platelet reactivity due, at least in part, to a pro-oxidant milieu. The aim of this study was to investigate platelet reactivity in T2DM (n = 103) or HC (n = 61) patients (aspirin, 100 mg/day) and its correlation with biomarkers of redox function including the superoxide anion scavenger superoxide dismutase (SOD) and the in vivo marker of oxidative stress urinary 8-iso-prostaglandin F2α. As results, in T2DM and HC subjects the prevalence of high on-aspirin platelet reactivity was comparable when both non-COX-1-dependent and COX-1-dependent assays were performed, and platelet reactivity is associated with a lower SOD activity that in a stepwise linear regression appears as the only predictor of platelet reactivity. To conclude, in T2DM and HC, similarly, the impairment of redox equilibrium associated with a decrease ...Continue Reading

References

Jan 1, 1992·Annual Review of Biochemistry·D C Wallace
Jun 21, 1990·The New England Journal of Medicine·G DavìC Patrono
Jan 1, 1995·Annual Review of Biochemistry·I Fridovich
Nov 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·P StrålinS L Marklund
Mar 10, 1999·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·P HarrisonS J Machin
Jul 27, 2001·The American Journal of Cardiology·P A GumE J Topol
Sep 24, 2002·The Annals of Pharmacotherapy·Patricia A Howard
Oct 26, 2002·JAMA : the Journal of the American Medical Association·Giovanni DavìCarlo Patrono
Jan 11, 2003·BMJ : British Medical Journal·Maribeth FriendMichael Miller
Mar 26, 2003·Journal of the American College of Cardiology·Paolo GreseleGeremia B Bolli
Jun 27, 2003·Cellular and Molecular Life Sciences : CMLS·I A M RelouE Malle
Apr 24, 2004·Free Radical Research·Samar Basu
Aug 12, 2004·Journal of Thrombosis and Haemostasis : JTH·P FerroniG Davì
Aug 24, 2004·Current Vascular Pharmacology·Patrizia FerroniGiovanni Davi
Sep 24, 2004·Archives of Gerontology and Geriatrics·Teslime AtliOrhan Canbolat
Oct 4, 2005·Journal of the American College of Cardiology·Andrew O MareeDesmond J Fitzgerald
Jan 18, 2006·Journal of the American College of Cardiology·Francesca SantilliCarlo Patrono
Apr 13, 2006·JAMA : the Journal of the American Medical Association·Louis MonnierClaude Colette
Sep 19, 2006·The International Journal of Biochemistry & Cell Biology·Marian ValkoJoshua Telser
Dec 21, 2006·Nature Clinical Practice. Cardiovascular Medicine·Carlo Patrono, Bianca Rocca
Jan 24, 2007·Thrombosis Research·Huyen A TranJohn W Eikelboom
Jan 17, 2008·Diabetologia·R AjjanP J Grant
Jun 10, 2008·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Arun NatarajanSally M Marshall
Oct 8, 2008·Circulation·John W EikelboomUNKNOWN Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) Investigators
Oct 16, 2008·Current Vascular Pharmacology·Giovanni AnfossiMariella Trovati
Mar 12, 2009·Current Medicinal Chemistry·Francesca SantilliGiovanni Davì
Jun 13, 2009·Best Practice & Research. Clinical Endocrinology & Metabolism·Bernd Stratmann, Diethelm Tschoepe
Feb 24, 2011·Circulation·José Luis Ferreiro, Dominick J Angiolillo
Jul 5, 2011·Redox Report : Communications in Free Radical Research·Joanna RybkaJózef Kędziora

❮ Previous
Next ❯

Citations

Jun 25, 2021·Platelets·Nameer Van OosteromRobert Bird

❮ Previous
Next ❯

Methods Mentioned

BETA
enzyme-linked immunosorbent assay
ELISA

Software Mentioned

SPSS

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.